Literature DB >> 1846317

Production of large amounts of hydrogen peroxide by human tumor cells.

T P Szatrowski1, C F Nathan.   

Abstract

Few nonphagocytic cells are known to generate reactive oxygen intermediates. Based on horseradish peroxidase-dependent, catalase-inhibitable oxidation of fluorescent scopoletin, seven human tumor cell lines constitutively elaborated H2O2 at rates (up to 0.5 nmol/10(4) cells/h) large enough that cumulative amounts at 4 h were comparable to the amount of H2O2 produced by phorbol ester-triggered neutrophils. Superoxide dismutase-inhibitable ferricytochrome c reduction was detectable at much lower rates. H2O2 production was inhibited by diphenyleneiodonium, a flavoprotein binder (concentration producing 50% inhibition, 0.3 microM), and diethyldithiocarbamate, a divalent cation chelator (concentration producing 50% inhibition, 3 microM), but not by cyanide or azide, inhibitors of electron transport, or by agents that inhibit xanthine oxidase, polyamine oxidase, or cytochrome P450. Cytochrome b559, present in human phagocytes and lymphocytes, was undetectable in these tumor cells by a sensitive spectrophotometric method. Mouse fibroblasts transfected with human tyrosinase complementary DNA made melanin, but not H2O2. Constitutive generation of large amounts of reactive oxygen intermediates, if it occurs in vivo, might contribute to the ability of some tumors to mutate, inhibit antiproteases, injure local tissues, and therefore promote tumor heterogeneity, invasion, and metastasis.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1846317

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  667 in total

Review 1.  Reactive oxygen intermediates involved in cellular regulation.

Authors:  B Meier
Journal:  Protoplasma       Date:  2001       Impact factor: 3.356

2.  Subcortical low intensity on MR images of meningitis, viral encephalitis, and leptomeningeal metastasis.

Authors:  Jae Hee Lee; Dong Gyu Na; Kyu H Choi; Ki Jun Kim; Jae Wook Ryoo; Sung Yong Lee; Yeon-Lim Suh
Journal:  AJNR Am J Neuroradiol       Date:  2002-04       Impact factor: 3.825

3.  Oxidative damage and cancer.

Authors:  Terry D Oberley
Journal:  Am J Pathol       Date:  2002-02       Impact factor: 4.307

4.  Silent repair accounts for cell cycle specificity in the signaling of oxidative DNA lesions.

Authors:  C Leroy; C Mann; M C Marsolier
Journal:  EMBO J       Date:  2001-06-01       Impact factor: 11.598

5.  Regulation of lung cancer cell migration and invasion by reactive oxygen species and caveolin-1.

Authors:  Sudjit Luanpitpong; Siera Jo Talbott; Yon Rojanasakul; Ubonthip Nimmannit; Varisa Pongrakhananon; Liying Wang; Pithi Chanvorachote
Journal:  J Biol Chem       Date:  2010-10-05       Impact factor: 5.157

Review 6.  Exploiting oxidative microenvironments in the body as triggers for drug delivery systems.

Authors:  Shivanjali Joshi-Barr; Caroline de Gracia Lux; Enas Mahmoud; Adah Almutairi
Journal:  Antioxid Redox Signal       Date:  2014-04-15       Impact factor: 8.401

7.  Natural Product Evodiamine with Borate Trigger Unit: Discovery of Potent Antitumor Agents against Colon Cancer.

Authors:  Xinglin Li; Shanchao Wu; Guoqiang Dong; Shuqiang Chen; Zonglin Ma; Dan Liu; Chunquan Sheng
Journal:  ACS Med Chem Lett       Date:  2020-02-28       Impact factor: 4.345

8.  Sporadic activation of an oxidative stress-dependent NRF2-p53 signaling network in breast epithelial spheroids and premalignancies.

Authors:  Elizabeth J Pereira; Joseph S Burns; Christina Y Lee; Taylor Marohl; Delia Calderon; Lixin Wang; Kristen A Atkins; Chun-Chao Wang; Kevin A Janes
Journal:  Sci Signal       Date:  2020-04-14       Impact factor: 8.192

9.  Superior therapeutic index of calmangafodipir in comparison to mangafodipir as a chemotherapy adjunct.

Authors:  Jan Olof G Karlsson; Tino Kurz; Susanne Flechsig; Jacques Näsström; Rolf Gg Andersson
Journal:  Transl Oncol       Date:  2012-12-01       Impact factor: 4.243

10.  A distinct metabolic signature of human colorectal cancer with prognostic potential.

Authors:  Yunping Qiu; Guoxiang Cai; Bingsen Zhou; Dan Li; Aihua Zhao; Guoxiang Xie; Houkai Li; Sanjun Cai; Dong Xie; Changzhi Huang; Weiting Ge; Zhanxiang Zhou; Lisa X Xu; Weiping Jia; Shu Zheng; Yun Yen; Wei Jia
Journal:  Clin Cancer Res       Date:  2014-02-13       Impact factor: 12.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.